Tag: kappa bioscience
M&A Update: Vitamin K2 Company to Join Balchem
Hampton, NY—Balchem Corporation has signed a definitive agreement to acquire Kappa Bioscience AS. Kappa offers K2VITAL a branded synthetic vitamin K2. Balchem is acquiring...
People News: May 2022
Tom Chapman is the new CEO and Executive Director of the Organic Trade Association (OTA). Chapman’s hiring concludes a planned succession process for outgoing...
Kappa Forms Scientific & Medical Board to Expand Vitamin K2 Knowledge Base
Oslo, Norway—Kappa Bioscience has formed a “Blue Ribbon” Scientific and Medical Advisory Board, to support and expand the scientific knowledge base for Vitamin K2,...
Vitamin K Status Correlates with COVID-19 Inflammation, Research Finds
Oslo, Norway—Vitamin K status is heavily associated with COVID-19-related inflammation—more strongly, in fact, than vitamin D deficiency, according to a new article published in...
Study Confirms Association Between COVID-19 and Vitamin K Status
Oslo, Norway—A new study supported by Kappa Bioscience has confirmed that vitamin K status is lower in hospitalized patients with COVID-19, compared to a...
Kappa Bioscience Attains Carbon Neutral Workforce
Oslo, Norway—Kappa Bioscience’s workforce is now wholly carbon neutral, according to a post on LinkedIn.
Kappa partnered with Ecologi to offset its employees’ carbon footprint...
Kappa Bioscience Expanding in the U.S.
Oslo, Norway—Kappa Bioscience is expanding its business in the United States, according to a press release.
“Our strategy requires focusing on one of the world’s...
AIDP Innovation Conference Focuses on Formulations with Magtein, Vitamin K2 MK-7, Vitamin D3
City of Industry, CA—Innovation is the core of successful new products, and AIDP will be helping to educate on opportunities at the Innovation Conference...
Free Vitamin K2 Program Announced
Oslo, Norway — Kappa Bioscience has launched a free vitamin K2 MK-7 quality testing program, which it announced at CPhI India. This will allow...
